143 related articles for article (PubMed ID: 34379542)
41. [The role of lymph node dysection in early and advanced stages of ovarian cancer].
Ismail E; Kornovski Y
Akush Ginekol (Sofiia); 2014; 53(8):17-20. PubMed ID: 25672085
[TBL] [Abstract][Full Text] [Related]
42. [Clinico-morphologic factors and retroperitoneal lymph node status in (intra-abdominal) stage I ovarian cancer].
Petru E; Pickel H; Lahousen M; Heydarfadai M; Winter R
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():214-5. PubMed ID: 8118275
[No Abstract] [Full Text] [Related]
43. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
44. Suprarenal lymph node dissection by the Kocher maneuver in the surgical management of ovarian cancer.
Song YJ; Suh DS; Kim KH; Na YJ; Lim MC; Park SY
Int J Gynecol Cancer; 2019 Mar; 29(3):647-648. PubMed ID: 30733277
[No Abstract] [Full Text] [Related]
45. Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?
Tangjitgamol S; Manusirivithaya S; Sheanakul C; Leelahakorn S; Sripramote M; Thawaramara T; Kaewpila N
Int J Gynecol Cancer; 2003; 13(3):297-302. PubMed ID: 12801259
[TBL] [Abstract][Full Text] [Related]
46. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
[TBL] [Abstract][Full Text] [Related]
47. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.
Chan JK; Urban R; Hu JM; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Kapp DS
Br J Cancer; 2007 Jun; 96(12):1817-22. PubMed ID: 17519907
[TBL] [Abstract][Full Text] [Related]
48. Lymphadenectomy for early-stage mucinous ovarian carcinoma.
Heyward QD; Nasioudis D; Cory L; Haggerty AF; Ko EM; Latif N
Int J Gynecol Cancer; 2021 Jan; 31(1):104-109. PubMed ID: 33243777
[TBL] [Abstract][Full Text] [Related]
49. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
[TBL] [Abstract][Full Text] [Related]
50. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
Salet-Lizée D; Alsary S
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
[TBL] [Abstract][Full Text] [Related]
51. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
[TBL] [Abstract][Full Text] [Related]
52. Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review.
Acs M; Piso P; Prader S
Anticancer Res; 2022 Jan; 42(1):13-24. PubMed ID: 34969704
[TBL] [Abstract][Full Text] [Related]
53. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
54. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
55. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
Prader S; Vollmar N; du Bois A; Heitz F; Schneider S; Ataseven B; Bommert M; Waltering KU; Heikaus S; Koch JA; Alesina PF; Traut A; Harter P
Gynecol Oncol; 2019 Jan; 152(1):76-81. PubMed ID: 30463683
[TBL] [Abstract][Full Text] [Related]
56. Sentinel lymph node in apparent early ovarian cancer: open technique.
Lago V; Bello P; Marina Martín MT; Montero B; Padilla-Iserte P; Lopez S; Matute L; Domingo S
Int J Gynecol Cancer; 2019 Nov; 29(9):1449. PubMed ID: 31575615
[No Abstract] [Full Text] [Related]
57. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
58. State of the art of surgery in advanced epithelial ovarian cancer.
Hacker NF
Ann Oncol; 2013 Dec; 24 Suppl 10():x27-32. PubMed ID: 24265399
[No Abstract] [Full Text] [Related]
59. [Our and foreign experience in surgical staging of early ovarian cancer].
Ivanov C
Akush Ginekol (Sofiia); 2011; 50(2):19-22. PubMed ID: 21913568
[TBL] [Abstract][Full Text] [Related]
60. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
